全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Safety Assessment of a Novel Topical Vehicle for Personalized Treatments in Acne

DOI: 10.4236/jcdsa.2022.124016, PP. 187-200

Keywords: Acne Vulgaris, Personalized Medicine, Irritation, Sensitization, Comedogenicity

Full-Text   Cite this paper   Add to My Lib

Abstract:

Acne vulgaris is a common inflammatory disease of the pilosebaceous unit, with a profound impact on the quality of life of patients. In this work, we aimed to study the safety characteristics of CleodermTM, a novel functional semisolid vehicle developed for the compounding of treatments for acne and oily skin. The primary and cumulative irritation and sensitization potential were evaluated in 54 healthy volunteers in a comparative single-blinded study, while the acnegenic and comedogenic potential of the product were assessed in 31 healthy volunteers with combination to oily skin through a non-comparative study. CleodermTM was applied (0.05 g/cm2) in filter paper discs in both studies. For the evaluation of the irritation and sensitization potential, the investigational product, or a control (0.9% NaCl) was applied to the right or left scapular area of the study subjects. No clinical reactions were observed during the induction or challenge phases, suggesting that CleodermTM presents no irritating or allergenic potential. Regarding acnegenicity and comedogenicity, no significant increase in the number of acne lesions linked to the application of the product in four areas of the face was reported, indicating that CleodermTM appears not to display acnegenic and comedogenic potential. Furthermore, over 60% of the study subjects exhibited a decrease in the number of acne lesions after product use. These results show that CleodermTM exhibited no irritating, sensitizing, acnegenic or comedogenic potential, and suggest that it can be considered safe under the study conditions and that the claims dermatologically tested, clinically tested, and non-comedogenic/acnegenic can be supported.

References

[1]  Bhate, K. and Williams, H.C. (2013) Epidemiology of Acne Vulgaris. British Journal of Dermatology, 168, 474-485. https://doi.org/10.1111/bjd.12149
[2]  Bagatin, E., Rocha, M.A.D., Da Freitas, T.H.P. and Costa, C.S. (2021) Treatment Challenges in Adult Female Acne and Future Directions. Expert Review of Clinical Pharmacology, 14, 687-701. https://doi.org/10.1080/17512433.2021.1917376
[3]  Goulden, V., Stables, I. and Cunliffe, W.J. (1999) Prevalence of Facial Acne in Adults. Journal of the American Academy of Dermatology, 41, 577-580.
https://doi.org/10.1016/S0190-9622(99)70300-2
[4]  Holzmann, R. and Shakery, K. (2014) Postadolescent Acne in Females. Skin Pharmacology and Physiology, 27, 3-8. https://doi.org/10.1159/000354887
[5]  Khunger, N. and Kumar, C. (2012) A Clinico-Epidemiological Study of Adult Acne: Is it Different from Adolescent Acne? Indian Journal of Dermatology, Venereology, and Leprology, 78, 335-341. https://doi.org/10.4103/0378-6323.95450
[6]  Tanghetti, E.A., Kawata, A.K., Daniels, S.R., Yeomans, K., Burk, C.T. and Callender, V.D. (2014) Understanding the Burden of Adult Female Acne. Journal of Clinical and Aesthetic Dermatology, 7, 22-30.
[7]  Del Rosso, J.Q., Stein-Gold, L., Lynde, C., Tanghetti, E. and Alexis, A.F. (2019) Truncal Acne: A Neglected Entity. Journal of Drugs in Dermatology, 18, 205-1208.
[8]  Poli, F., Auffret, N., Leccia, M.T., Claudel, J.P. and Dréno, B. (2020) Truncal Acne, What Do We Know? Journal of the European Academy of Dermatology and Venerology, 34, 2241-2246. https://doi.org/10.1111/jdv.16634
[9]  Scholz, C.F.P. and Kilian, M. (2016) The Natural History of Cutaneous Propionibacteria, and Reclassification of Selected Species within the Genus Propionibacterium to the Proposed Novel Genera Acidipropionibacterium Gen. Nov., Cutibacterium Gen. Nov. and Pseudopropionibacterium Gen. Nov. International Journal of Systematic and Evolutionary Microbiology, 66, 4422-4432.
https://doi.org/10.1099/ijsem.0.001367
[10]  Melnik, B.C. (2018) Acne Vulgaris: The Metabolic Syndrome of the Pilosebaceous Follicle. Clinics in Dermatology, 36, 29-40.
https://doi.org/10.1016/j.clindermatol.2017.09.006
[11]  Qidwai, A., Pandey, M., Pathak, S., Kumar, R. and Dikshit, A. (2017) The Emerging Principles for Acne Biogenesis: A Dermatological Problem of Puberty. Human Microbiome Journal, 4, 7-13. https://doi.org/10.1016/j.humic.2017.05.001
[12]  Chiu, A., Chon, S.Y. and Kimball, A.B. (2003) The Response of Skin Disease to Stress. Archives of Dermatology, 139, 897-900.
https://doi.org/10.1001/archderm.139.7.897
[13]  Niemeier, V., Kupfer, J. and Gieler, U. (2006) Acne Vulgaris—Psychosomatic Aspects. Journal Der Deutschen Dermatologischen Gesellschaft, 4, 1027-1036.
https://doi.org/10.1111/j.1610-0387.2006.06110.x
[14]  Poli, F., Dreno, B. and Verschoore, M. (2001) An Epidemiological Study of Acne in Female Adults: Results of a Survey Conducted in France. Journal of the European Academy of Dermatology and Venereology, 15, 541-545.
https://doi.org/10.1046/j.1468-3083.2001.00357.x
[15]  Green, J. and Sinclair, R.D. (2001) Perceptions of Acne Vulgaris in Final Year Medical Student Written Examination Answers. Australasian Journal of Dermatology, 42, 98-101. https://doi.org/10.1046/j.1440-0960.2001.00489.x
[16]  Mitchell, B.L., Saklatvala, J.R., Dand, N., et al. (2022) Genome-Wide Association Meta-Analysis Identifies 29 New Acne Susceptibility Loci. Nature Communications, 13, Article No. 702. https://doi.org/10.1038/s41467-022-28252-5
[17]  Mina-Vargas, A., Colodro-Conde, L., Grasby, K., et al. (2017) Heritability and GWAS Analyses of Acne in Australian Adolescent Twins. Twin Research and Human Genetics, 20, 541-549. https://doi.org/10.1017/thg.2017.58
[18]  Navarini, A.A., Simpson, M.A., Weale, M., et al. (2014) Genome-Wide Association Study Identifies Three Novel Susceptibility Loci for Severe Acne Vulgaris. Nature Communications, 5, Article No. 4020. https://doi.org/10.1038/ncomms5020
[19]  Bataille, V., Snieder, H., MacGregor, A.J., Sasieni, P. and Spector, T.D. (2002) The Influence of Genetics and Environmental Factors in the Pathogenesis of Acne: A Twin Study of Acne in Women. Journal of Investigative Dermatology, 119, 1317-1322. https://doi.org/10.1046/j.1523-1747.2002.19621.x
[20]  Evans, D.M., Kirk, K.M., Nyholt, D.R., Novac, C. and Martin, N.G. (2005) Teenage Acne Is Influenced by Genetic Factors. British Journal of Dermatology, 152, 579-581.
https://doi.org/10.1111/j.1365-2133.2005.06387.x
[21]  Petridis, C., Navarini, A.A., Dand, N., et al. (2018) Genome-Wide Meta-Analysis Implicates Mediators of Hair Follicle Development and Morphogenesis in Risk for Severe Acne. Nature Communications, 9, Article No.5075.
https://doi.org/10.1038/s41467-018-07459-5
[22]  He, L., Wu, W.J., Yang, J.K., et al. (2014) Two New Susceptibility Loci 1q24.2 and 11p11.2 Confer Risk to Severe Acne. Nature Communications, 5, Article No. 2870.
https://doi.org/10.1038/ncomms3870
[23]  Dréno, B., Bettoli, V., Araviiskaia, E., Sanchez Viera, M. and Bouloc, A. (2018) The Influence of Exposome on Acne. Journal of the European Academy of Dermatology and Venereology, 32, 812-819. https://doi.org/10.1111/jdv.14820
[24]  Oge’, L.K., Broussard, A. and Marshall, M.D. (2019) Acne Vulgaris: Diagnosis and Treatment. American Family Physician, 100, 475-484.
[25]  Stern, R.S. (2004) Dermatologists and Office-Based Care of Dermatologic Disease in the 21st Century. Journal of Investigative Dermatology Symposium Proceedings, 9, 126-130. https://doi.org/10.1046/j.1087-0024.2003.09108.x
[26]  Magin, P., Adams, J., Heading, G., Pond, D. and Smith, W. (2006) Psychological Sequelae of Acne Vulgaris: Results of a Qualitative Study. Canadian Family Physician Medecin de Famille Canadien, 52, 978-979.
[27]  Ozturk, P., Orhan, F.O., Ozer, A., Karakas, T., Oksuz, A.N. and Yetisir, N.Y. (2013) Assessment of Temperament and Character Profile with Anxiety and Depression in Patients with Acne. Balkan Medical Journal, 30, 161-166.
https://doi.org/10.5152/balkanmedj.2012.101
[28]  Timms, R.M. (2013) Moderate Acne as a Potential Barrier to Social Relationships: Myth or Reality? Psychology, Health & Medicine, 18, 310-320.
https://doi.org/10.1080/13548506.2012.726363
[29]  Cunliffe, W.J. (1986) Acne and Unemployment. British Journal of Dermatology, 115, 386-386. https://doi.org/10.1111/j.1365-2133.1986.tb05757.x
[30]  Greydanus, D.E., Azmeh, R., Cabral, M.D., Dickson, C.A. and Patel, D.R. (2021) Acne in the First Three Decades of Life: An Update of a Disorder with Profound Implications for All Decades of Life. Disease-A-Month, 67, Article ID: 101103.
https://doi.org/10.1016/j.disamonth.2020.101103
[31]  Gieler, U., Gieler, T. and Kupfer, J.P. (2015) Acne and Quality of Life—Impact and Management. Journal of the European Academy of Dermatology and Venereology, 29, 12-14. https://doi.org/10.1111/jdv.13191
[32]  Halvorsen, J.A., Stern, R.S., Dalgard, F., Thoresen, M., Bjertness, E. and Lien, L. (2011) Suicidal Ideation, Mental Health Problems, and Social Impairment Are Increased in Adolescents with Acne: A Population-Based Study. Journal of Investigative Dermatology, 131, 363-370. https://doi.org/10.1038/jid.2010.264
[33]  Koo, J.Y.M. and Smith, L.L. (1991) Psychologic Aspects of Acne. Pediatric Dermatology, 8, 185-188. https://doi.org/10.1111/j.1525-1470.1991.tb00856.x
[34]  Prabhakar, D., Peterson, E.L., Hu, Y., et al. (2018) Dermatologic Conditions and Risk of Suicide: A Case-Control Study. Psychosomatics, 59, 58-61.
https://doi.org/10.1016/j.psym.2017.08.001
[35]  Xu, S., Zhu, Y., Hu, H., et al. (2021) The Analysis of Acne Increasing Suicide Risk. Medicine, 100, e26035. https://doi.org/10.1097/MD.0000000000026035
[36]  Yang, Y.C., Tu, H.P., Hong, C.H., et al. (2014) Female Gender and Acne Disease Are Jointly and Independently Associated with the Risk of Major Depression and Suicide: A National Population-Based Study. Biomed Research International, 2014, Article ID: 625601. https://doi.org/10.1155/2014/625601
[37]  Zaenglein, A.L., Pathy, A.L., Schlosser, B.J., et al. (2016) Guidelines of Care for the Management of Acne Vulgaris. Journal of the American Academy of Dermatology, 74, 945-973. https://doi.org/10.1016/j.jaad.2015.12.037
[38]  Dréno, B., Bissonnette, R., Gagné-Henley, A., et al. (2018) Prevention and Reduction of Atrophic Acne Scars with Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in Subjects with Moderate or Severe Facial Acne: Results of a 6-Month Randomized, Vehicle-Controlled Trial Using Intra-Individual Comparison. American Journal of Clinical Dermatology, 19, 275-286. https://doi.org/10.1007/s40257-018-0352-y
[39]  Habeshian, K.A. and Cohen, B.A. (2020) Current Issues in the Treatment of Acne Vulgaris. American Academy of Pediatrics, 145, S225-S230.
https://doi.org/10.1542/peds.2019-2056L
[40]  Kolli, S.S., Pecone, D., Pona, A., Cline, A. and Feldman, S.R. (2019) Topical Retinoids in Acne Vulgaris: A Systematic Review. American Journal of Clinical Dermatology, 20, 345-365. https://doi.org/10.1007/s40257-019-00423-z
[41]  Leyden, J., Stein-Gold, L. and Weiss, J. (2017) Why Topical Retinoids Are Mainstay of Therapy for Acne. Dermatology and Therapy, 7, 293-304.
https://doi.org/10.1007/s13555-017-0185-2
[42]  Thiboutot, D.M., Dréno, B., Abanmi, A., et al. (2018) Practical Management of Acne for Clinicians: An International Consensus from the Global Alliance to Improve Outcomes in Acne. Journal of the American Academy of Dermatology, 78, S1-S23. https://doi.org/10.1016/j.jaad.2017.09.078
[43]  Helm, M.F., Farah, J.B., Carvalho, M., Farah, F.S. and Farah, R.S. (2017) Compounded Topical Medications for Diseases of the Skin: A Long Tradition Still Relevant Today. North American Journal of Medicine and Science, 10, 116-118.
[44]  Green, L.J., Lain, E., Prunty, T. and Rhoades, R. (2022) Enhancing Topical Pharmacotherapy for Acne and Rosacea: Vehicle Choices and Outcomes. Journal of Clinical Aesthetic Dermatology, 15, 36-40.
[45]  Hoffman Ba, L.K., Bhatia, N., Zeichner, J. and Kircik, L.H. (2018) Topical Vehicle Formulations in the Treatment of Acne. Journal of Drugs in Dermatology, 17, s6-s10.
[46]  Polonini, H., Zander, C. and Radke, J. (2021) Cleoderm Clarifying Cream: A Novel, Topical Vehicle Using Plant-Based Excipients and Actives Targeting Acne and Oily Skin. Journal of Cosmetics, Dermatological Sciences and Applications, 11, 381-399.
https://doi.org/10.4236/jcdsa.2021.114031
[47]  Goossens, A., Huygens, S. and Gilissen, L. (2020) Irritant Reactions to Leave-On Cosmetics and Other Products. Contact Dermatitis, 82, 227-228.
https://doi.org/10.1111/cod.13438
[48]  Dooms-Goossens, A. (1993) Cosmetics as Causes of Allergic Contact Dermatitis. Cutis, 52, 316-320.
[49]  Wijnhoven, S., Ezendam, J., Schuur, A.G., Van Loveren, H. and Van Engelen, J.G.M. (2008) Allergens in Consumer Products. RIVM Report 320025001.
[50]  Ross, G.A. (2006) Perspective on the Safety of Cosmetic Products: A Position Paper of the American Council on Science and Health. International Journal of Toxicology, 25, 269-277. https://doi.org/10.1080/10915810600746049
[51]  Waranuch, N., Wisutthathum, S., Tuanthai, S., et al. (2021) Safety Assessment on Comedogenicity of Dermatological Products Containing D-Alpha Tocopheryl Acetate in Asian Subjects: A Double-Blind Randomized Controlled Trial. Contemporary Clinical Trials Communications, 23, Article ID: 100834.
https://doi.org/10.1016/j.conctc.2021.100834
[52]  Fitzpatrick, T.B. (1988) The Validity and Practicality of Sun-Reactive Skin Types I through VI. Archives of Dermatology, 124, 869-871.
https://doi.org/10.1001/archderm.1988.01670060015008
[53]  Kligman, A.M. and Wooding, W.M.A. (1967) Method for the Measurement and Evaluation of Irritants on Human Skin. Journal of Investigative Dermatology, 49, 78-94. https://doi.org/10.1038/jid.1967.106
[54]  (2001) Fisher’s Contact Dermatitis. Contact Dermatitis, 45, 191-191.
https://doi.org/10.1034/j.1600-0536.2001.045003191.x
[55]  World Medical Association (2013) World Medical Association Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects. The Journal of American Medical Association, 310, 2191-2194.
https://doi.org/10.1001/jama.2013.281053
[56]  Working Group on Good Clinical Practices (WG/GCP) (2002) Good Clinical Practices: Document of the Americas. Pan American Conference on Drug Regulatory Harmonization, Washington, 2002.
[57]  Good Clinical Practices: ICH Harmonised Tripartite Guidelines (2016) Guideline for Good Clinical Practice E6 (R2). International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use ICH.
[58]  Feldman, S.R. and Chen, D.M. (2011) How Patients Experience and Manage Dryness and Irritation from Acne Treatment. Journal of Drugs in Dermatology, 10, 605-608.
[59]  Goh, C., Noppakun, N., Micali, G., et al. (2016) Meeting the Challenges of Acne Treatment in Asian Patients: A Review of the Role of Dermocosmetics as Adjunctive Therapy. Journal of Cutaneous and Aesthetic Surgery, 9, 85-92.
https://doi.org/10.4103/0974-2077.184043
[60]  Sevimli Dikicier, B. (2019) Topical Treatment of Acne Vulgaris: Efficiency, Side Effects, and Adherence Rate. Journal of International Medical Research, 47, 2987-2992. https://doi.org/10.1177/0300060519847367
[61]  Tan, J., Alexis, A., Baldwin, H., et al. (2021) The Personalised Acne Care Pathway— Recommendations to Guide Longitudinal Management from the Personalising Acne: Consensus of Experts. Journal of the American Academy of Dermatology, 5, 101-111.
https://doi.org/10.1016/j.jdin.2021.09.006
[62]  Ilary, H. and Aldwin, E.B. (2006) Tricks for Improving Compliance with Acne Therapy. Dermatologic Therapy, 19, 224-236.
https://doi.org/10.1111/j.1529-8019.2006.00078.x
[63]  Mayba, J.N. and Gooderham, M.J. (2018) A Guide to Topical Vehicle Formulations. Journal of Cutaneous Medicine and Surgery, 22, 207-212.
https://doi.org/10.1177/1203475417743234
[64]  Milam, E.C. and Rieder, E.A. (2021) An Approach to Cosmeceuticals. In: Evan, A.R. and Richard, G.F., Eds., Essential Psychiatry for the Aesthetic Practitioner, Wiley, New York, 42-48. https://doi.org/10.1002/9781119680116.ch4
[65]  Moy, R.L. and Levenson, C. (2017) Sandalwood Album Oil as a Botanical Therapeutic in Dermatology. Journal of Clinical Aesthetic Dermatology, 10, 34-39.
[66]  Barros, B.S. and Zaenglein, A.L. (2017) The Use of Cosmeceuticals in Acne: Help or Hoax? American Journal of Clinical Dermatology, 18, 159-163.
https://doi.org/10.1007/s40257-016-0249-6
[67]  Chomnawang, M.T., Surassmo, S., Nukoolkarn, V.S. and Gritsanapan, W. (2005) Antimicrobial Effects of Thai Medicinal Plants against Acne-Inducing Bacteria. Journal of Ethnopharmacology, 101, 330-333. https://doi.org/10.1016/j.jep.2005.04.038
[68]  Fabbrocini, G. and Saint Aroman, M. (2014) Cosmeceuticals Based on Rhealba Oat Plantlet Extract for the Treatment of Acne Vulgaris. Journal of the European Academy of Dermatology and Venereology, 28, 1-6. https://doi.org/10.1111/jdv.12791
[69]  Lall, N., Mahomoodally, M.F., Esposito, D., et al. (2020) Editorial: Cosmeceuticals from Medicinal Plants. Frontiers in Pharmacology, 11, Article 1149.
https://doi.org/10.3389/fphar.2020.01149
[70]  Poomanee, W., Chaiyana, W., Mueller, M., Viernstein, H., Khunkitti, W., Leelapornpisid, P. (2018) In Vitro Investigation of Anti-Acne Properties of Mangifera indica L. Kernel Extract and Its Mechanism of Action against Propionibacterium Acnes. Anaerobe, 52, 64-74. https://doi.org/10.1016/j.anaerobe.2018.05.004
[71]  Tsai, T.H., Tsai, T.H., Wu, W.H., Tseng, J.T.P. and Tsai, P.J. (2010) In Vitro Antimicrobial and Anti-Inflammatory Effects of Herbs against Propionibacterium Acnes. Food Chemistry, 119, 964-968. https://doi.org/10.1016/j.foodchem.2009.07.062

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133